FDA Brief

Warning letters Food

FDA warning letter to

Aspire Pharmaceuticals, Inc.

Issued Nov 22, 2022Posted Apr 4, 2023Division of Human and Animal Food Operations East II

CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.